In the case of LGALS1, a recent report characterized the induction of resistance to a variety of anticancer drugs following ectopic expression of galectin-3 in chronic myelogenous leukemia cells [30]. Here, LGALS1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.